Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1988 1
1989 1
1993 1
1995 1
1996 1
1997 4
1998 2
1999 1
2000 1
2001 1
2002 3
2003 4
2004 11
2005 10
2006 5
2007 4
2008 10
2009 10
2010 5
2011 2
2012 4
2013 7
2014 9
2015 13
2016 10
2017 16
2018 11
2019 6
2020 17
2021 20
2022 19
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Results by year
Filters applied: . Clear all
Page 1
Basic principles of real-time quantitative PCR.
Arya M, Shergill IS, Williamson M, Gommersall L, Arya N, Patel HR. Arya M, et al. Among authors: arya n. Expert Rev Mol Diagn. 2005 Mar;5(2):209-19. doi: 10.1586/14737159.5.2.209. Expert Rev Mol Diagn. 2005. PMID: 15833050 Review.
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Mathieu C, Dandona P, Gillard P, Senior P, Hasslacher C, Araki E, Lind M, Bain SC, Jabbour S, Arya N, Hansen L, Thorén F, Langkilde AM; DEPICT-2 Investigators. Mathieu C, et al. Among authors: arya n. Diabetes Care. 2018 Sep;41(9):1938-1946. doi: 10.2337/dc18-0623. Epub 2018 Jul 19. Diabetes Care. 2018. PMID: 30026335 Free article. Clinical Trial.
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group*. Kosiborod M, et al. Among authors: arya n. Circulation. 2017 Jul 18;136(3):249-259. doi: 10.1161/CIRCULATIONAHA.117.029190. Epub 2017 May 18. Circulation. 2017. PMID: 28522450 Free PMC article. Clinical Trial.
Lignes directrices de pratique clinique pour les personnes sans-abri, logées précairement, ou ayant connu l’itinérance.
Pottie K, Kendall CE, Aubry T, Magwood O, Andermann A, Salvalaggio G, Ponka D, Bloch G, Brcic V, Agbata E, Thavorn K, Hannigan T, Bond A, Crouse S, Goel R, Shoemaker E, Wang JZJ, Mott S, Kaur H, Mathew C, Hashmi SS, Saad A, Piggott T, Arya N, Kozloff N, Beder M, Guenter D, Muckle W, Hwang S, Stergiopoulos V, Tugwell P. Pottie K, et al. Among authors: arya n. CMAJ. 2020 Oct 13;192(41):E1225-E1241. doi: 10.1503/cmaj.190777-f. CMAJ. 2020. PMID: 33051325 Free PMC article. French. No abstract available.
Peptide-Chitosan Engineered Scaffolds for Biomedical Applications.
Kulkarni N, Shinde SD, Jadhav GS, Adsare DR, Rao K, Kachhia M, Maingle M, Patil SP, Arya N, Sahu B. Kulkarni N, et al. Among authors: arya n. Bioconjug Chem. 2021 Mar 17;32(3):448-465. doi: 10.1021/acs.bioconjchem.1c00014. Epub 2021 Mar 3. Bioconjug Chem. 2021. PMID: 33656319 Review.
Peace and health: bridging the north-south divide.
Arya N. Arya N. Med Confl Surviv. 2017 Jun;33(2):87-91. doi: 10.1080/13623699.2017.1360459. Epub 2017 Aug 9. Med Confl Surviv. 2017. PMID: 28791893 No abstract available.
The chemistry and biological potential of azetidin-2-ones.
Arya N, Jagdale AY, Patil TA, Yeramwar SS, Holikatti SS, Dwivedi J, Shishoo CJ, Jain KS. Arya N, et al. Eur J Med Chem. 2014 Mar 3;74:619-56. doi: 10.1016/j.ejmech.2014.01.002. Epub 2014 Jan 10. Eur J Med Chem. 2014. PMID: 24531200 Review.
199 results